There is increasing evidence suggesting that the deregulated expression of S100P associated with the tumor growth, progression and metastasis of various types of human cancer 94, such as breast 95, nasopharyngeal carcinoma 96 and pancreatic cancer 97. The gene discussed is S100P; the disease is neoplasm.